Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Exercise/Conversion of 55,000 ANRO shares, $127.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Alto Neuroscience, Inc. (ANRO) | Exercise/Conversion | 55,000 | $127.6K |
| Oct 2, 2026 | Alto Neuroscience, Inc. (ANRO) | Exercise/Conversion | 56,455 | $132.7K |
| Mar 4, 2026 | Alto Neuroscience, Inc. (ANRO) | Tax Withholding | 2,806 | $55.3K |
| Feb 13, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 200,000 | n/a |
| Jul 8, 2025 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 44,962 | n/a |
| Feb 7, 2025 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 135,000 | n/a |
| Apr 1, 2024 | Alto Neuroscience, Inc. (ANRO) | Purchase | 1,600 | $25.3K |
| Mar 5, 2024 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 19,153 | n/a |
| Feb 7, 2024 | Alto Neuroscience, Inc. (ANRO) | Purchase | 1,563 | $25.0K |